These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 10827363)

  • 21. Therapeutic efficacy of chloroquine and sulfadoxine/pyrimethamine against Plasmodium falciparum infection in Somalia.
    Warsame M; Abdillahi A; Duale ON; Ismail AN; Hassan AM; Mohamed A; Warsame A
    Bull World Health Organ; 2002; 80(9):704-8. PubMed ID: 12378287
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Plasmodium falciparum: evaluation of a quantitative nucleic acid sequence-based amplification assay to predict the outcome of sulfadoxine-pyrimethamine treatment of uncomplicated malaria.
    Omar SA; Mens PF; Schoone GJ; Yusuf A; Mwangi J; Kaniaru S; Omer GA; Schallig HD
    Exp Parasitol; 2005 May; 110(1):73-9. PubMed ID: 15804381
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development of resistance by Plasmodium falciparum to sulfadoxine/pyrimethamine in Amhara Region, Northwestern Ethiopia.
    Kassa M; Sileshi M; Mohammed H; Taye G; Asfaw M
    Ethiop Med J; 2005 Jul; 43(3):181-7. PubMed ID: 16370550
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Artesunate + amodiaquine and artesunate + sulphadoxine-pyrimethamine for treatment of uncomplicated malaria in Democratic Republic of Congo: a clinical trial with determination of sulphadoxine and pyrimethamine-resistant haplotypes.
    Swarthout TD; van den Broek IV; Kayembe G; Montgomery J; Pota H; Roper C
    Trop Med Int Health; 2006 Oct; 11(10):1503-11. PubMed ID: 17002724
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Patterns of resistance and DHFR/DHPS genotypes of Plasmodium falciparum in rural Tanzania prior to the adoption of sulfadoxine-pyrimethamine as first-line treatment.
    Eriksen J; Mwankusye S; Mduma S; Kitua A; Swedberg G; Tomson G; Gustafsson LL; Warsame M
    Trans R Soc Trop Med Hyg; 2004 Jun; 98(6):347-53. PubMed ID: 15099990
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Current status of malaria chemotherapy and the role of pharmacology in antimalarial drug research and development.
    Na-Bangchang K; Karbwang J
    Fundam Clin Pharmacol; 2009 Aug; 23(4):387-409. PubMed ID: 19709319
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Open randomized study of artesunate-amodiaquine vs. chloroquine-pyrimethamine-sulfadoxine for the treatment of uncomplicated Plasmodium falciparum malaria in Nigerian children.
    Sowunmi A; Fehintola FA; Adedeji AA; Gbotosho GO; Tambo E; Fateye BA; Happi TC; Oduola AM
    Trop Med Int Health; 2005 Nov; 10(11):1161-70. PubMed ID: 16262741
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The efficacy of sulfadoxine-pyrimethamine alone and in combination with chloroquine for malaria treatment in rural Eastern Sudan: the interrelation between resistance, age and gametocytogenesis.
    A-Elbasit IE; Elbashir MI; Khalil IF; Alifrangis M; Giha HA
    Trop Med Int Health; 2006 May; 11(5):604-12. PubMed ID: 16640612
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Resistance of Plasmodium falciparum to antimalarials: practical implications and control prospects].
    Onori E
    Parassitologia; 1981 Dec; 23(1-3):31-62. PubMed ID: 6760055
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Antimalarial drug resistance].
    Le Bras J; Musset L; Clain J
    Med Mal Infect; 2006 Aug; 36(8):401-5. PubMed ID: 16854546
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular epidemiology of malaria in Cameroon. XXI. Baseline therapeutic efficacy of chloroquine, amodiaquine, and sulfadoxine-pyrimethamine monotherapies in children before national drug policy change.
    Basco LK; Ngane VF; Ndounga M; Same-Ekobo A; Youmba JC; Abodo RT; Soula G
    Am J Trop Med Hyg; 2006 Sep; 75(3):388-95. PubMed ID: 16968911
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Point mutations in the dihydrofolate reductase and dihydropteroate synthase genes of Plasmodium falciparum and resistance to sulfadoxine-pyrimethamine in Sri Lanka.
    Hapuarachchi HC; Dayanath MY; Bandara KB; Abeysundara S; Abeyewickreme W; de Silva NR; Hunt SY; Sibley CH
    Am J Trop Med Hyg; 2006 Feb; 74(2):198-204. PubMed ID: 16474070
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of sulfadoxine-pyrimethamine with and without chloroquine for uncomplicated malaria in Nigeria.
    Pitmang SL; Thacher TD; Madaki JK; Egah DZ; Fischer PR
    Am J Trop Med Hyg; 2005 Mar; 72(3):263-6. PubMed ID: 15772318
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Plasmodium falciparum dihydrofolate reductase Val-16 and Thr-108 mutation associated with in vivo resistance to antifolate drug: a case study.
    Biswas S
    Indian J Malariol; 2001; 38(3-4):76-83. PubMed ID: 12125519
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Polymorphisms in Plasmodium falciparum dhfr and dhps genes and age related in vivo sulfadoxine-pyrimethamine resistance in malaria-infected patients from Nigeria.
    Happi CT; Gbotosho GO; Folarin OA; Akinboye DO; Yusuf BO; Ebong OO; Sowunmi A; Kyle DE; Milhous W; Wirth DF; Oduola AM
    Acta Trop; 2005 Sep; 95(3):183-93. PubMed ID: 16023986
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Therapeutic efficacy of sulfadoxine-pyrimethamine and the prevalence of molecular markers of resistance in under 5-year olds in Brazzaville, Congo.
    Ndounga M; Tahar R; Basco LK; Casimiro PN; Malonga DA; Ntoumi F
    Trop Med Int Health; 2007 Oct; 12(10):1164-71. PubMed ID: 17956498
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Assessment of the efficacy of antimalarial drugs in Tarapacá, in the Colombian Amazon basin].
    Osorio L; Pérez Ldel P; González IJ
    Biomedica; 2007 Mar; 27(1):133-40. PubMed ID: 17546230
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular surveillance of drug-resistance associated mutations of Plasmodium falciparum in south-west Tanzania.
    Schönfeld M; Barreto Miranda I; Schunk M; Maduhu I; Maboko L; Hoelscher M; Berens-Riha N; Kitua A; Löscher T
    Malar J; 2007 Jan; 6():2. PubMed ID: 17224049
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mechanisms of resistance of malaria parasites to antifolates.
    Gregson A; Plowe CV
    Pharmacol Rev; 2005 Mar; 57(1):117-45. PubMed ID: 15734729
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.